A comparison of pentane-1,5-diol to other diols for use in dermatology

Expert Opinion on Investigational Drugs

Volumn 17, Issue 4, 2008, Pages 601-610

  Sundberg, Jeanette Jacobson ^a   Faergemann, Jan ^b  

^a PULS AB   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

1,5 dihydroxypentane; Antimicrobial; Dermatology; Diols; Enhancer; Glycol; Pentamethylene glycol; Pentane 1,5 diol; Pentylene glycol; Percutaneous; Pharmaceutical; Skin; Topical

Indexed keywords

1,3 BUTANEDIOL; 2 METHYL 2,4 DIOL; 2 METHYL 2,4 PENTANE DIOL; 2,5 HEXANEDIOL; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; COSMETIC; DERMATOLOGICAL AGENT; DIOL DERIVATIVE; ESTROGEN; ETHANANE 1,2 DIOL; ETHANE 1,2 DIOL; HEXYLENE GLYCOL; HORMONE DERIVATIVE; HYDROCORTISONE; LOCAL ANESTHETIC AGENT; MOMETASONE FUROATE; PENTANE 1,2 DIOL; PENTANE 1,5 DIOL; PLACEBO; PROPYLENE GLYCOL; TERBINAFINE; THYROID HORMONE DERIVATIVE; TIRATRICOL; UNCLASSIFIED DRUG; 1,5 PENTANEDIOL; 1,5-PENTANEDIOL; DRUG VEHICLE; GLYCOL; PRESERVATIVE;

ANTIBIOTIC RESISTANCE; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; APPLICATION SITE BURNING; ARTICLE; ATOPIC DERMATITIS; BACTERIAL INFECTION; BACTERIAL STRAIN; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONCENTRATION RESPONSE; CONTACT DERMATITIS; CORNEA INJURY; DANDRUFF; DRUG ABSORPTION; DRUG COST; DRUG EFFICACY; DRUG FORMULATION; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG METABOLISM; DRUG POTENCY; DRUG SAFETY; DRUG SCREENING; DRUG STRUCTURE; DRUG TRANSPORT; DRY SKIN; ECZEMA; EYE IRRITATION; FOLLICULITIS; FUNGAL STRAIN; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HERPES; HUMAN; HYDROPHILICITY; MENOPAUSAL SYNDROME; MINIMUM INHIBITORY CONCENTRATION; MONOTHERAPY; MYCOSIS; NONHUMAN; PATIENT COMPLIANCE; PRURITUS; PSORIASIS; SEBORRHEIC DERMATITIS; SKIN DISEASE; SKIN INFECTION; SKIN IRRITATION; SKIN PAIN; TINEA VERSICOLOR; VIRUS INHIBITION; VIRUS STRAIN; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; COMPARATIVE STUDY; MICROBIOLOGY; REVIEW; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME; VEHICLES; VIROLOGY;

ADMINISTRATION, TOPICAL; ANIMALS; ANTI-INFECTIVE AGENTS; CHEMISTRY, PHARMACEUTICAL; DERMATOLOGIC AGENTS; DRUG COMPOUNDING; GLYCOLS; HUMANS; MOLECULAR STRUCTURE; PRESERVATIVES, PHARMACEUTICAL; SKIN DISEASES, INFECTIOUS; TREATMENT OUTCOME; VEHICLES;

EID: 42149101216     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.17.4.601     Document Type: Article

References (42)

1. Faergemann J. Elocon Novum. A product from Ambria Dermatology AB, Sweden. Manuscript 2007. Data on file
2. European Commission European Chemicals Bureau. IUCLID Dataset, 2000 Feb 18. CAS no. 107-41-5. EINECS no 203-489-0
3. Faergemann J. The in vitro activity of pentane-1,5-diol and other diols against Propionibacterium acnes, Staphylococcus aureus and Candida albicans. Manuscript 2007. Data on file
4. Sax NI. Dangerous Properties of Industrial Materials. 4th edition. New York-Cincinnati-Toronto-London-Melbourne: Van Nostrand Reihold Company; 1975
5. Smyth HF. Range finding toxicity data: List VI. Ind Hug Assoc J 1962;23:95-7
6. Rowe VK, Wolf MA. Glycols, Table 50.1. Physical and chemical properties of common glycols (diols). In: Patty's Industrial Hygiene and Toxicology. 3rd edition. Clayton GD, Clayton FE, editors. New York: John Wiley & Sons; 1982. p. 3818-9
7. Frankenfeld JW, Miller SA. High energy food supplements comprising linear aliphatic 1,3-diols. US3791241 (1974)
8. Frankefeld JW. Preservation of grain with aliphatic 1,3-diols and their esters. J Agric Food Chem 1975;23:418-25
9. Barr M. Propylene glycol: a solvent-vehicle of increased importance in dermatology. Am J Pharmacol 1965;137:107-14
10. Browning. Glycols and derivatives. Chapter 12. In: Toxicity and Metabolism of Industrial Solvents. Amsterdam: Elsevier Publishing Company; 1965. p. 594-600, 663-5
11. Goldsmith LA. Propylene glycol. Int J Dermatol 1978;17:703-5
12. Faergemann J, Hedner T, Larsson P The in vitro activity of pentane-1,5-diol against aerobic bacteria. A new antimicrobial agent for topical usage?. Acta Derm Venereol 2005;85:203-5
13. Swanbeck G, Faergemann J. Preparation of topical treatment of infections caused by virus, bacterial and fungi. US5369129 (1994)
14. Ambria Dermatology AB. A comparison comprising at least 3 different diols. WO057616A1 (2006)
15. Faergemann J, Fredriksson T. The antimycotic activity in vitro of five diols. Sabouraudia 1980;18:287-93
16. Lykke N. Experiments with pentane-1,5-diol against herpes simplex virus. Manuscript 1991. Data on file
17. Faergemann J, Swanbeck G. Topical use of pentane-1,5-diol in the treatment of herpes simplex labialis. Manuscript 1992. Data on file
18. Robertson OH, Loosli CC, Puck TT, et al. The protection of mice against influenza virus by means of propylene glycol vapour. Science 1941;612-3
19. Faergemann J, Wahlstrand B, Hedner T, et al. Pentane-1,5-diol as a percutaneous absorption enhancer. Arch Dermatol Res 2005;297:261-5
20. Halén C, Faergemann J. Percutaneous absorption of terbinafine. Examination work (Bachelor of Pharmacy Program). Manuscript 2006. Data on file
21. Faergemann J, Hedner T. The in vitro water binding capacity of pentane-1,5-diol, propane-1,2-diol and urea. 2002. Data on file
22. Sandström MH, Faergemann J. Prognosis and prognostic factors in adult patients with atopic dermatitis: a long-term follow-up questionnaire study. Br J Dermatol 2004;150:103-10
23. Gessner P, Parked V, Williams RT, Studies in detoxification; 80. The metabolism of glycols. Biochemistry 1960;74:1-5
24. National Library of Medicine. ChemID plus Advanced Full Record. Available from: http://chem.sis.nlm.nih.gov/chemidplus
25. European Commission European Chemicals Bureau. IUCLID dataset; 2000 Feb 18. CAS no. 111-29-5. EINECS no 203-854-4
26. Fischer AA.The management of propylene glycol sensitive patients. Cutis 1980;24-26, 29, 31, 44
27. Natumin Pharma AB, Huskvarna, Sweden, 2007. Data on file
28. Faergemann J. Atopic dermatitis and fungi. Clin Microbiol Rev 2002;15:545-63
29. Faergemann J. Treatment of atopic dermatitis with 1% hydrocortisone and 25% pentane-1,5-diol - a pilot study in patients. 2003. Data on file
30. Sandström MH, Särnhult T, Hedner T, Faergemann J. Treatment of atopic dermatitis with 1% hydrocortisone and 25% pentane-1,5-diol: effect on Staphylococcus aureus. Acta Derm Venereol 2006;86:372-3
31. Williams HC, Burney P, Pembroke A, Hay R. The UK working-party's diagnostic criteria for atopic-dermatitis. III. Independent hospital validation. Br J Dermatol 1994;131:406-16
32. Faergemann J. Short-term treatment of dandruff with a combination of propylene glycol solution and shampoo. Cutis 1988;42:146
33. Faergemann J, Fredriksson T. Propylene glycol in the treatment of - tinea versicolor. Acta Dermato Venerol (Stockholm) 1980;60:92-3
34. Faergemann J. Mangagement of seborrheic dermatitis and pityriais versicolor. Am J Clin Dermatol 2000;1:75-80
35. Gallo R, Viglizzo G, Vecchio F, Parodi A. Allergic contact dermatitis from pentylene glycol in an emollient cream, with possible co-sensitization to resveratrol. Contact Dermatitis 2003;48:176-7
36. Swensson Å, The Nordic expert group of limit documentation 44. Propylene glycol. Work and Health, Scientific Writing Series 1983;27:1-38
37. Wikipedia entry on propylene glycol. Available from: http://en.wikipedia.org/wiki/Propylene_glycol [Last accessed 18 February 2008]
38. Andersen KE, Storrs FJ. Skin irritation caused by propylene glycols. Hautartz 1982;33:12-4
39. Horiguchi Y, Honda T, Fujii S, et al. A case of allergic contact dermatitis from propylene glycol in an ultrasonic gel, sensitized at a leakage skin injury due to transcatheter arterial chemoembolization for hepatocellular carcinoma. Int J Dermatol 2005;44:681-3
40. Heine G, Schnuch A, Uter W, Worn M. Frequency of contact allergy in German children and adolescents patch rested between 1995 and 2002: results from the Information Network of Departments of Dermatology and the German Contact Dermatitis Research Group. Contact Dermatitis 2004;51:111-7
41. Löffler H, Becker D, Brasch J, et al. The German Contact Dermatitis Research Group (DKG). Simultaneous sodium lauryl sulphate testing improves the diagnostic validity of allergic patch tests. Results from a prospective multicentre study of the German Contact Dermatitis Research Group (Deutsche Kontaktallergie-Gruppe, DKG). Br J Dermatol 2005;52:709-19
42. Vliet E. Screaming To Be Heard: Hormonal Connections That Women Suspect and Doctors Ignore. New York: M Evans and Company, Inc.; 1995